The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2

被引:17
|
作者
Bardwell, A. Jane [1 ]
Lagunes, Leonila [1 ]
Zebarjedi, Ronak [1 ]
Bardwell, Lee [1 ]
机构
[1] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
cancer; cell signaling; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); protein complex; protein kinase; protein-protein interaction; scaffold protein; IQGAP1; PROLINE-RICH LIGANDS; HIGH-AFFINITY INTERACTION; YES-ASSOCIATED PROTEIN; DOCKING SITES; SUBSTRATE PHOSPHORYLATION; TRANSCRIPTION FACTOR; C-JUN; KINASE; ACTIVATION; CANCER;
D O I
10.1074/jbc.M116.767087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitogen-activated protein kinase (MAPK) scaffold proteins, such as IQ motif containing GTPase activating protein 1 (IQGAP1), are promising targets for novel therapies against cancer and other diseases. Such approaches require accurate information about which domains on the scaffold protein bind to the kinases in the MAPK cascade. Results from previous studies have suggested that the WW domain of IQGAP1 binds to the cancer-associated MAPKs ERK1 and ERK2, and that this domain might thus offer a new tool to selectively inhibit MAPK activation in cancer cells. The goal of this work was therefore to critically evaluate which IQGAP1 domains bind to ERK1/2. Here, using quantitative in vitro binding assays, we show that the IQ domain of IQGAP1 is both necessary and sufficient for binding to ERK1 and ERK2, as well as to the MAPK kinases MEK1 and MEK2. Furthermore, we show that the WW domain is not required for ERK-IQGAP1 binding, and contributes little or no binding energy to this interaction, challenging previous models of how WW-based peptides might inhibit tumorigenesis. Finally, we show that the ERK2-IQGAP1 interaction does not require ERK2 phosphorylation or catalytic activity and does not involve known docking recruitment sites on ERK2, and we obtain an estimate of the dissociation constant (K-d) for this interaction of 8 m. These results prompt a re-evaluation of published findings and a refined model of IQGAP scaffolding.
引用
收藏
页码:8750 / 8761
页数:12
相关论文
共 50 条
  • [41] Hierarchical scaffolding of an ERK1/2 activation pathway
    Susanne Vetterkind
    Ransom H Poythress
    Qian Qian Lin
    Kathleen G Morgan
    Cell Communication and Signaling, 11
  • [42] IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload
    Sbroggio, Mauro
    Carnevale, Daniela
    Bertero, Alessandro
    Cifelli, Giuseppe
    De Blasio, Emanuele
    Mascio, Giada
    Hirsch, Emilio
    Bahou, Wadie F.
    Turco, Emilia
    Silengo, Lorenzo
    Brancaccio, Mara
    Lembo, Giuseppe
    Tarone, Guido
    CARDIOVASCULAR RESEARCH, 2011, 91 (03) : 456 - 464
  • [43] Signal transduction protein ERK1 and ERK2 are therapeutic targets for the inhibition of retinal angiogenesis.
    Bullard, LE
    Penn, JS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S140 - S140
  • [44] The Ras GTPase-activating-like protein IQGAP1 is downregulated in human diabetic nephropathy and associated with ERK1/2 pathway activation
    Hua Zhou
    Chunlei Yao
    Ao Bian
    Jun Qian
    Xiufen Zhao
    Yanting Zhao
    Weiwei Wang
    Changying Xing
    Molecular and Cellular Biochemistry, 2014, 391 : 21 - 25
  • [45] ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-dependent gene transcription in response to interferon-γ
    Hu, JB
    Roy, SK
    Shapiro, PS
    Rodig, SR
    Reddy, SPM
    Platanias, LC
    Schreiber, RD
    Kalvakolanu, DV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) : 287 - 297
  • [46] The Ras GTPase-activating-like protein IQGAP1 is downregulated in human diabetic nephropathy and associated with ERK1/2 pathway activation
    Zhou, Hua
    Yao, Chunlei
    Bian, Ao
    Qian, Jun
    Zhao, Xiufen
    Zhao, Yanting
    Wang, Weiwei
    Xing, Changying
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 391 (1-2) : 21 - 25
  • [47] Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis
    Chan, Gordon
    Gu, Shengqing
    Neel, Benjamin G.
    BLOOD, 2013, 121 (18) : 3594 - 3598
  • [48] Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2
    Wiemhoefer, Anne
    Stargardt, Anita
    van der Linden, Wouter A.
    Renner, Maria C.
    van Kesteren, Ronald E.
    Stap, Jan
    Raspe, Marcel A.
    Tomkinson, Birgitta
    Kessels, Helmut W.
    Ovaa, Huib
    Overkleeft, Herman S.
    Florea, Bogdan
    Reits, Eric A.
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (08) : 2177 - 2193
  • [49] Peptide substrates for assaying the in situ regulation of ERK1/ERK2 activity.
    Haycock, JW
    FASEB JOURNAL, 1996, 10 (06): : 1542 - 1542
  • [50] HYPEROSMOTIC UREA ACTIVATES ERK1 AND ERK2 IN MIMCD3 CELLS
    COHEN, DM
    GULLANS, SER
    CHIN, WW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 359 - 359